Skip to content

Myofascial Release in Shoulder Pathologies

Effectiveness of Myofascial Release in Pathologies of the Shoulder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04944446
Enrollment
44
Registered
2021-06-29
Start date
2018-09-15
Completion date
2021-01-15
Last updated
2021-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Humerus Fracture, Rotator Cuff Injuries

Keywords

Shoulder, Pathology, Myofascial release, Clinical trial

Brief summary

Shoulder pathology has a high prevalence in the field of musculoskeletal diagnoses, as well as being a common etiology in cases of disability. Passive and active-assisted kinesitherapy are used in the physiotherapy protocol. These techniques sometimes lead to feedback of fear and increased sensation of pain on the part of the patient that can slow or hinder the optimal recovery. A randomized clinical trial is intended to demonstrate that techniques for myofascial release of muscles important in the biomechanics of the shoulder, it is more effective than kinesitherapy in improving myofascial and also by eliminating the aforementioned unwanted effects and, therefore, improving the recovery of these processes.

Detailed description

The purpose of this study was to compare the efficacy of myofascial therapy and kinesitherapy in improving function in shoulder pathology with prolonged immobilization. Design Prospective, single-blind randomized controlled trial. Setting Inpatient department of a secondary university hospital. Participants Shoulder pain patients (N=44) were consecutively recruited and randomly assigned to an intervention or control group. Interventions Patients were randomly assigned to a Control Group, to which conventional kinesitherapy was applied, or to the intervention group to which a Myofascial therapy protocol was applied. Both groups completed a therapeutic exercise program based on specific mobilization and strengthening exercises. Main Outcome Measures The QuickDash questionnaire was the primary outcome, visual analog scale and the passive range of motion of the shoulder joint, grades were the secondary outcomes. The outcomes were evaluated at baseline (T0) and at 4 (T2),

Interventions

OTHERTreatment

Myofascial release of various muscle groups Treatment of mobilization of the shoulder joint

Sponsors

University of Cadiz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Double (Participant, Outcomes Assessor) external evaluator

Intervention model description

Randomized controlled longitudinal experimental study

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Be between 20 and 80 years old. * Patients who have been immobilized due to the following diagnoses: Suture of the rotator cuff or fracture of the proximal extremity of the humerus. * Have signed the informed consent of acceptance in the participation of the study

Exclusion criteria

* Present neurological pathology. * Be subdued corticoid therapy. * Have anticoagulant treatment or have had it less than a month ago. * Insulin-dependent diabetic patients. * Patients with hemophilia. * Having diagnosed a psychological or psychiatric pathology. * Non-intervened displaced humerus fractures.

Design outcomes

Primary

MeasureTime frameDescription
Functional capacityBaselineDash Scale. Minimum: 0 Maximum: 100. Higher scores mean a worse outcome
Shoulder joint mobilityBaselineGoniometer Records
Degree of painBaselineVisual Analog Scale. Minimum: 0 Maximum: 10. Higher scores mean a worse outcome

Secondary

MeasureTime frameDescription
Pathology of access to the studyBaselineSuture of the rotator cuff or fracture of the proximal limb of the humerus
AgeBaselineYears
SexBaselineMan or woman

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026